The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Amelioration of lupus-like autoimmune disease in NZB/WF1 mice after treatment with a blocking monoclonal antibody specific for complement component C5.
Open accessAbstract
New Zealand black x New Zealand white (NZB/W) F1 mice spontaneously develop an autoimmune syndrome with notable similarities to human systemic lupus erythematosus. Female NZB/WF1 mice produce high titers of antinuclear antibodies and invariably succumb to severe glomerulonephritis by 12 months of age. Although the development of the immune-complex nephritis is accompanied by abundant local and systemic complement activation, the role of proinflammatory complement components in disease progression has not been established. In this study we have examined the contribution of activated terminal complement proteins to the pathogenesis of the lupus-like autoimmune disease. Female NZB/W F1 mice were treated with a monoclonal antibody (mAb) specific for the C5 component of complement that blocks the cleavage of C5 and thus prevents the generation of the potent proinflammatory factors C5a and C5b-9. Continuous therapy with anti-C5 mAb for 6 months resulted in significant amelioration of the course of glomerulonephritis and in markedly increased survival. These findings demonstrate an important role for the terminal complement cascade in the progression of renal disease in NZB/W F1 mice, and suggest that mAb-mediated C5 inhibition may be a useful approach to the therapy of immune-complex glomerulonephritis in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inducible Gene Targeting in Mice
Kühn, R., Schwenk, F., Aguet, M., & Rajewsky, K. (1995) · Science · doi:10.1126/science.7660125 · Cited by 1,641
Andrews, B. S., Eisenberg, R. A., Theofilopoulos, A. N., Izui, S., Wilson, C. B., McConahey, P. J., Murphy, E. D., Roths, J. B., & Dixon, F. J. (1978) · The Journal of experimental medicine · doi:10.1084/jem.148.5.1198 · Cited by 1,598
Murine Models of Systemic Lupus Erythematosus
Theofilopoulos, A. N., & Dixon, F. J. (1985) · Advances in Immunology · doi:10.1016/s0065-2776(08)60342-9 · Cited by 1,550
Treatment of Murine Lupus with CTLA4Ig
Finck, B. K., Linsley, P. S., & Wofsy, D. (1994) · Science · doi:10.1126/science.7520604 · Cited by 668
Ishida, H., Muchamuel, T., Sakaguchi, S., Andrade, S., Menon, S., & Howard, M. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.1.305 · Cited by 532
C5A Anaphylatoxin and Its Seven Transmembrane-Segment Receptor
Gerard, C., & Gerard, N. P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.004015 · Cited by 416
Labow, M. A., Norton, C. R., Rumberger, J. M., Lombard-Gillooly, K. M., Shuster, D. J., Hubbard, J., Bertko, R., Knaack, P. A., Terry, R. W., Harbison, M. L., et al. (1994) · Immunity · doi:10.1016/1074-7613(94)90041-8 · Cited by 370
Wang, Y., Rollins, S. A., Madri, J. A., & Matis, L. A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.19.8955 · Cited by 360
Self-citationFc Receptors Initiate the Arthus Reaction: Redefining the Inflammatory Cascade
Sylvestre, D. L., & Ravetch, J. V. (1994) · Science · doi:10.1126/science.8066448 · Cited by 321
Specific and redundant roles of Src and Fyn in organizing the cytoskeleton
Thomas, S. M., Soriano, P., & Imamoto, A. (1995) · Nature · doi:10.1038/376267a0 · Cited by 316
Cytotoxic antibodies trigger inflammation through Fc receptors
Clynes, R., & Ravetch, J. V. (1995) · Immunity · doi:10.1016/1074-7613(95)90155-8 · Cited by 250
Datta, S. K., Patel, H., & Berry, D. (1987) · The Journal of experimental medicine · doi:10.1084/jem.165.5.1252 · Cited by 227
Rinder, C. S., Rinder, H. M., Smith, B. R., Fitch, J. C., Smith, M. J., Tracey, J. B., Matis, L. A., Squinto, S. P., & Rollins, S. A. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118195 · Cited by 213
Self-citationGenetic analysis of the NZB contribution to lupus-like autoimmune disease in (NZB x NZW)F1 mice.
Drake, C. G., Babcock, S. K., Palmer, E., & Kotzin, B. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.4062 · Cited by 166
Development of C5a receptor antagonists. Differential loss of functional responses.
Konteatis, Z. D., Siciliano, S. J., Riper, G. V., Molineaux, C. J., Pandya, S., Fischer, P. A., Rosen, H., Mumford, R. A., & Springer, M. S. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.9.4200 · Cited by 151
Membrane signaling by complement C5b-9, the membrane attack complex
Nicholson-Weller, A., & Halperin, J. A. (1993) · Immunologic Research · doi:10.1007/bf02918256 · Cited by 149
Rudofsky, U. H., Evans, B. D., Balaban, S. L., Mottironi, V. D., & GABRIELSEN, A. E. (1993) · PubMed · Cited by 130
Frei, Y., Lambris, J. D., & Stockinger, B. (1987) · Molecular and Cellular Probes · doi:10.1016/0890-8508(87)90022-3 · Cited by 90
Complement-specific antibodies: Designing novel anti-inflammatories
Matis, L. A., & Rollins, S. A. (1995) · Nature Medicine · doi:10.1038/nm0895-839 · Cited by 80
Self-citationComplement in the Pathophysiology and Diagnosis of Human Diseases
Dalmasso, A. P. (1986) · CRC Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408368609110272 · Cited by 78
Anti-CD4 monoclonal antibody therapy suppresses autoimmune disease in MRL/Mp-lpr/lpr mice
Jabs, D. A., Burek, C. L., Hu, Q., Kuppers, R. C., Lee, B., & Prendergast, R. A. (1992) · Cellular Immunology · doi:10.1016/0008-8749(92)90166-m · Cited by 69
Self-citationThe Molecular Origin of Anti-DNA Antibodies
Behar, S. M., Corbet, S., Diamond, B., & Scharff, M. D. (1989) · International Reviews of Immunology · doi:10.3109/08830188909086988 · Cited by 14
Cited by
Generation of C5a in the absence of C3: a new complement activation pathway
Huber-Lang, M., Sarma, J. V., Zetoune, F. S., Rittirsch, D., Neff, T. A., McGuire, S. R., Lambris, J. D., Warner, R. L., Flierl, M. A., Hoesel, L. M., et al. (2006) · Nature Medicine · doi:10.1038/nm1419 · Cited by 975
Rother, R. P., Rollins, S. A., Mojcik, C. F., Brodsky, R. A., & Bell, L. (2007) · Nature Biotechnology · doi:10.1038/nbt1344 · Cited by 778
Mollnes, T. E., Brekke, O., Fung, M. S. C., Fure, H., Christiansen, D., Bergseth, G., Videm, V., Lappegård, K. T., Köhl, J., & Lambris, J. D. (2002) · PubMed · doi:10.1182/blood.v100.5.1869.h81702001869_1869_1877 · Cited by 455
The role of neutrophils and NETosis in autoimmune and renal diseases
Gupta, S., & Kaplan, M. J. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.71 · Cited by 433
The Central Role of the Alternative Complement Pathway in Human Disease
Thurman, J. M., & Holers, V. M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1305 · Cited by 432
Metadata
- Authors
- Wang, Y., Hu, Q., Madri, J. A., Rollins, S. A., Chodera, A., & Matis, L. A.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1996-08-06
- Volume
- 93
- Issue
- 16
- Pages
- 8563-8568
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2060179486
- Cited by
- 336
- References
- 22
- FWCI
- 10.63
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.